News & Events
MD Anderson News
-
MD Anderson study shows FGL2 protein may be an effective target for glioblastoma
News Release
-
A dogged pursuit of aggressive brain cancer
Conquest
-
MD Anderson's Glioblastoma Moon Shot
Cancer Newsline
-
Nanoparticle Targeted STAT3 Immune Expression receives CPRIT research funding
News Release
-
Glioblastoma added to MD Anderson's Moon Shots Program
News Release
-
My Moon Shot - Lanie Rose
Promise
-
Seeking a Cure - Ivy Foundation
Promise
-
Protein FGL2 May Have Potential as Therapy Target for Brain Cancer
News Release
Other Media
-
Immunotherapy offers a promising bet against brain cancer
Nature Outlook
-
FGL2-Directed Immunotherapy Under Exploration in Glioblastoma
Targeted Oncology
-
Dr. Heimberger on FGL2 as a Regulator of Tumor-Mediated Immune Suppression
OncLive
-
Cancer stem cells suppress immune response against brain tumor
News Release
-
Twelve Early-Career NIH Researchers Receive Prestigious Award
NIH
-
Heal Thyself Part Two
CBS News
-
Eye to Eye: Neurosurgeon's Fight Against Cancer
CBS News
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.